Tianrui Yang
Peking Union Medical College Hospital
17 Papers
Tianrui Yang is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Zihao Wang,Yaning Wang,Tianrui Yang,Hao Xing,Yuekun Wang,Lu Gao,Xiaopeng Guo,Bing Xing,Yu Wang,Wenbin Ma +9 more
TL;DR: Based on their stemness signature, GBM patients were divided into two subtypes via consensus clustering, and patients in Stemness Subtype I presented significantly better overall survival (OS) but poorer progression-free survival (PFS) than patients in SBS II.
111
PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential.
TL;DR: Recent clinical trials of anti-PD-1/PD-L1 monotherapy, studies with neoadjuvant strategies, and preclinical and clinical studies of combination immunotherapies for GBM are reviewed.
81
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
Xiaopeng Guo,Lingui Gu,Yilin Li,Zhiyao Zheng,Wenlin Chen,Hao Xing,Yixin Shi,De-ping Liu,Tianrui Yang,Yu Xia,Junlin Li,Jiaming Wu,Kun Zhang,Tingyu Liang,Hai Wang,Qianshuo Liu,S. A. Jin,T. Qu,Siying Guo,Huan-Huan Li,Wenbin Ma +20 more
TL;DR: In this paper , the clinical, radiological, molecular, and survival features of Glioblastoma (GBM) under the current classification scheme and explore survival determinants were investigated.
Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas.
Ziren Kong,Chendan Jiang,Yiwei Zhang,Sirui Liu,Delin Liu,Zeyu Liu,Wenlin Chen,Penghao Liu,Tianrui Yang,Yuelei Lyu,Yuelei Lyu,Dachun Zhao,Hui You,Yu Wang,Wenbin Ma,Feng Feng +15 more
TL;DR: The MRI-based radiomics signature can differentiate 1p/19q co-deletion status in LGG with or without predetermined IDH status, and 3D-CE-T1-weighted radiomics features are more favorable than SC-CE/T2/weighted features in the establishment of radiomics signatures.
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
Xiaopeng Guo,Yixin Shi,De-ping Liu,Yilin Li,Wenlin Chen,Yaning Wang,Yuekun Wang,Hao Xing,Yu Xia,Junlin Li,Jiaming Wu,Tingyu Liang,Hai Feng Wang,Qianshuo Liu,S. A. Jin,T. Qu,Siying Guo,Huan-Huan Li,Tianrui Yang,Kun Zhang,Yu Wang,Wenbin Ma +21 more
TL;DR: The 5th edition of the World Health Organization (WHO) classification of central nervous system tumors incorporated specific molecular alterations into the categorization of gliomas and the major revision of the classification scheme effectuates significant changes in the diagnosis and management of Glioma as mentioned in this paper .